Industry update tracker: February 2026
Our monthly index of company press releases and announcements shaping the real-world evidence and market access landscape.
ASTHO partners with Veritas Data Research and HealthVerity to launch the first-of-its-kind public health data consortium
The Association of State and Territorial Health Officials (ASTHO) announced a partnership with Veritas Data Research and HealthVerity that establishes a first-of-its-kind public health data consortium. This novel consortium brings together ASTHO, jurisdictional health departments and private partners united in a shared mission to improve public health outcomes through enhanced data access and quality, and to address long-standing challenges that hinder US public health data infrastructure.
BC Platforms partners with OmicsBank to expand access to large-scale real-world and multi-omics data from India and the UAE
BC Platforms, a global leader in healthcare data, technology, and analytics announced a strategic partnership with OmicsBank, a healthcare AI-ready data infrastructure company specializing in enabling access to large-scale, research-ready longitudinal and multi-modal real-world clinical and multi-omics datasets from emerging markets.
Flatiron launches first-of-its-kind AI-powered global prostate cancer datasets
Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data (RWD), announced their first Panoramic datasets in the UK and Germany for patients with prostate cancer. Globally, prostate cancer affects nearly 1.5 million patients annually and has a rapidly evolving treatment landscape, yet real-world evidence (RWE) remains limited and infeasible to study across international borders.
NashBio announces key leadership roles, advancing technological enablement and access to RWD
Nashville Biosciences LLC, a leading real-world, multi-omics data company, announced the appointment of Wacey Richards to Chief Technology Officer (CTO) and Elizabeth Ann Stringer to Chief Operating Officer (COO).
OneMedNet partners with ViuHealth to enhance autoimmune dataset scale, accelerating recurring revenue from life sciences and AI customers
OneMedNet Corporation, a leading provider of regulatory-grade, AI-ready RWD, has announced a strategic partnership with ViuHealth, a digital health company specializing in autoimmune disease populations. This partnership expands OneMedNet’s autoimmune clinical ontology, to the OneMedNet iRWD™ platform – powered by Palantir Foundry – further increasing the scale, diversity, and longitudinal depth of its regulatory-grade RWD. Under the agreement, ViuHealth will provide ongoing, longitudinal autoimmune disease data, strengthening OneMedNet’s portfolio of high-value specialty datasets and supporting research, AI model development, HEOR initiatives, and regulatory-aligned use cases.
OneMedNet announces next phase of commercial launch with its RWD platform powered by Palantir Foundry
OneMedNet Corporation also announced the next phase of commercial launch with its RWD Platform powered by Palantir Foundry. Following the successful November 10, 2025, demonstration of live feeds, subscription access, and AI-driven search at major tradeshows, the Company is actively converting customer evaluations into commercial subscriptions. Early results highlight superior performance, speed and analytical depth, reinforcing OneMedNet’s position for life sciences and healthcare organizations generating RWE.
Precision AQ expands senior leadership team to strengthen global AI, data strategy, evidence synthesis and economic modeling capabilities
Precision AQ, a global commercialization partner built to guide life science innovators through commercial complexity, today announced the appointment of two new leaders who will accelerate the company's international growth and enhance delivery of AI-enabled, data-driven solutions for global biopharma partners. Emma Hawe joins as Senior Vice President, Managing Director, Evidence Synthesis & Decision Modelling, and Yahya Anvar as Senior Vice President, Data Strategy & AI.
Promptly Health, PaLaDIn and TREAT-NMD build Interactium® for EU rare diseases
Promptly Health, a European leader in access to RWD and patient-generated health insights, announced a strategic collaboration with TREAT-NMD and the PaLaDIn consortium to develop the Interactium®, a digital platform designed to transform how data is collected, connected, and leveraged to improve outcomes for people living with rare neuromuscular diseases.
PurpleLab expands access to real-world healthcare data via Databricks and Snowflake
PurpleLab®, the healthtech company empowering teams to leverage insights that improve health outcomes, announced the availability of its provider and claims-based data solutions through the Databricks Marketplace and Snowflake Marketplace. The company is expanding how healthcare and life sciences teams discover, evaluate, and access RWD directly within their existing cloud analytics environments.
SEQSTER announces expanded partnership with Praxis Precision Medicines to accelerate clinical trials in CNS disorders
SEQSTER, the leading healthcare technology company and the data connection, collection, and orchestration layer for patient health data, and Praxis Precision Medicines, Inc., announced the expansion of a successful partnership to accelerate clinical trials, data collection, and RWE generation across Praxis's clinical development programs.
Segmed partners with Verily to expand access to real-world imaging data
Segmed, Inc., a leader in real-world medical imaging and multimodal data for research and AI development, has announced a partnership with Verily, a precision health AI company. Through this collaboration, Segmed is making accessible its de-identified, diagnostic-grade imaging and associate clinical data available by enabling researchers to explore curated datasets within Verily's precision health platform, Pre Exchange and Workbench environment, secure platforms designed to accelerate precision health research and discovery. The partnership reflects Segmed's commitment to supporting rigorous, privacy-first research while lowering barriers to entry for investigators across academia, life sciences, and healthcare AI.
Thermo Fisher Scientific expands RWD interoperability and linkage through strategic collaboration with Datavant
Thermo Fisher Scientific, the world leader in serving science, announced a strategic data collaboration with Datavant, the data collaboration platform trusted for healthcare, to make it easier for pharmaceutical and biotech companies to connect RWD with clinical research – helping them generate stronger evidence, faster. Thermo Fisher’s PPD™ clinical research business and Datavant will enable secure connection and analysis of RWD, spanning RWD enrichment of randomized clinical trials, PPD™ CorEvitas™ Clinical Registries and PPD™ Evidera™ solutions.
Veradigm brings patient voice to healthcare research with new RWD survey solution
Veradigm, a leading provider of clinical and revenue cycle solutions for independent practices, announced a new patient‑reported outcomes survey capability that brings the patient voice directly into RWE generation. The new solution gives life sciences organizations timely, privacy‑preserving insights directly from patients, adding essential context to clinical and observational research.
Verana Health introduces industry first end-to-end urologic-oncology datasets to support research
Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through RWD, has introduced new urologic-oncology datasets to support research for bladder and prostate cancer treatments. The datasets offer researchers comprehensive longitudinal insights into disease detection, treatment, and outcomes for patients affected with these malignancies.
| Register for free today to become a member of The Evidence Base and receive the latest news straight to your inbox. |